Induction pEmetrexed and cisplatin followed by maintenance pEmetrexed versus carboplatin plus paclitaxel plus bEvacizumab followed by maintenance bEvacizumab: A Quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE)

Domenico Galetta, Salvatore Pisconti, Saverio Cinieri, Giovanni Luigi Pappagallo, Vittorio Gebbia, Nicola Borsellino, Evaristo Maiello, Antonio Rinaldi, Michele Montrone, Pietro Rizzo, Nicola Marzano, Nicola Sasso, Antonio Febbraro, Giuseppe Colucci

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Induction pEmetrexed and cisplatin followed by maintenance pEmetrexed versus carboplatin plus paclitaxel plus bEvacizumab followed by maintenance bEvacizumab: A Quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE)'. Together they form a unique fingerprint.

Medicine & Life Sciences